Literature DB >> 22589373

Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis.

Tatiana Barskova1, Luna Gargani, Serena Guiducci, Silvia Bellando Randone, Cosimo Bruni, Giulia Carnesecchi, Maria Letizia Conforti, Francesco Porta, Alberto Pignone, Davide Caramella, Eugenio Picano, Marco Matucci Cerinic.   

Abstract

BACKGROUND: A high percentage of patients with systemic sclerosis (SSc) develop interstitial lung disease (ILD) during the course of the disease. Promising data have recently shown that lung ultrasound (LUS) is able to detect ILD by the evaluation of B-lines (previously called ultrasound lung comets), the sonographic marker of pulmonary interstitial syndrome.
OBJECTIVE: To evaluate whether LUS is reliable in the screening of ILD in patients with SSc.
METHODS: Fifty-eight consecutive patients with SSc (54 women, mean age 51±14 years) who underwent a high resolution CT (HRCT) scan of the chest were also evaluated by LUS for detection of B-lines. Of these, 32 patients (29 women, mean age 51±15 years) fulfilled the criteria for a diagnosis of very early SSc.
RESULTS: At HRCT, ILD was detected in 88% of the SSc population and in 41% of the very early SSc population. A significant difference in the number of B-lines was found in patients with and without ILD on HRCT (57±53 vs 9±9; p<0.0001), with a concordance rate of 83%. All discordant cases were false positive at LUS, providing a sensitivity and negative predictive value of 100% in both SSc and very early SSc.
CONCLUSIONS: ILD may be detected in patients with very early SSc. The presence of B-lines at LUS examination correlates with ILD at HRCT. LUS is very sensitive for detecting ILD even in patients with a diagnosis of very early SSc. The use of LUS as a screening tool for ILD may be feasible to guide further investigation with HRCT.

Entities:  

Mesh:

Year:  2012        PMID: 22589373     DOI: 10.1136/annrheumdis-2011-201072

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  42 in total

1.  Utilize lung ultrasound B-lines and KL-6 to monitor anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis-associated interstitial lung disease: a case report and literature review.

Authors:  Yukai Wang; Shaoqi Chen; Zhangzhang Lin; Jianqun Lin; Xuezhen Xie; Qisheng Lin; Guangzhou Du; Xiufeng Huang; Marco Matucci-Cerinic; Daniel E Furst
Journal:  Clin Rheumatol       Date:  2019-02-11       Impact factor: 2.980

Review 2.  Ultrasound as a potential tool for the assessment of interstitial lung disease in rheumatic patients. Where are we now?

Authors:  Marwin Gutierrez; Marika Tardella; Luis Rodriguez; Jaime Mendoza; Denise Clavijo-Cornejo; Antonio García; Chiara Bertolazzi
Journal:  Radiol Med       Date:  2019-07-02       Impact factor: 3.469

Review 3.  Is there any role for thoracic ultrasound for interstitial lung disease underlying rheumatologic conditions?

Authors:  Domenico Sambataro; Gianluca Sambataro; Ylenia Dal Bosco; Davide Campagna; Riccardo Polosa
Journal:  Intern Emerg Med       Date:  2017-03-04       Impact factor: 3.397

4.  Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression.

Authors:  Luna Gargani; Cosimo Bruni; Daniele De Marchi; Chiara Romei; Serena Guiducci; Silvia Bellando-Randone; Giovanni Donato Aquaro; Alessia Pepe; Emanuele Neri; Stefano Colagrande; Fabio Falaschi; Alberto Moggi-Pignone; Alessandro Pingitore; Marco Matucci-Cerinic
Journal:  Clin Rheumatol       Date:  2020-11-07       Impact factor: 2.980

Review 5.  Ultrasound in systemic sclerosis. A multi-target approach from joint to lung.

Authors:  Marwin Gutierrez; Carlos Pineda; Tomas Cazenave; Marco Piras; Gian Luca Erre; Antonella Draghessi; Rossella De Angelis; Walter Grassi
Journal:  Clin Rheumatol       Date:  2014-02-18       Impact factor: 2.980

Review 6.  Ultrasound in the interstitial pulmonary fibrosis. Can it facilitate a best routine assessment in rheumatic disorders?

Authors:  Marwin Gutierrez; Luis Enrique Gomez-Quiroz; Denise Clavijo-Cornejo; Carlos A Lozada; Ana C Lozada-Navarro; Roxana U Miranda Labra; Javier Fernandez-Torres; Guadalupe Sanchez-Bringas; Fausto Salaffi; Chiara Bertolazzi; Carlos Pineda
Journal:  Clin Rheumatol       Date:  2016-06-21       Impact factor: 2.980

Review 7.  Novel Imaging Approaches in Systemic Sclerosis-Associated Interstitial Lung Disease.

Authors:  Sydney B Montesi; Peter Caravan
Journal:  Curr Rheumatol Rep       Date:  2019-04-25       Impact factor: 4.592

Review 8.  Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review.

Authors:  Kundan Iqbal; Clive Kelly
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-12       Impact factor: 5.346

9.  Utility of pulmonary ultrasound to identify interstitial lung disease in patients with rheumatoid arthritis.

Authors:  Natalia Mena-Vázquez; Francisco Gabriel Jimenez-Núñez; Francisco Javier Godoy-Navarrete; Sara Manrique-Arija; María Carmen Aguilar-Hurtado; Carmen María Romero-Barco; Inmaculada Ureña-Garnica; F Espildora; María Isabel Padin-Martín; Antonio Fernández-Nebro
Journal:  Clin Rheumatol       Date:  2021-02-21       Impact factor: 2.980

Review 10.  Use of ultrasound to diagnose and monitor interstitial lung disease in rheumatic diseases.

Authors:  Esther F Vicente-Rabaneda; David A Bong; Santos Castañeda; Ingrid Möller
Journal:  Clin Rheumatol       Date:  2021-06-23       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.